List of insiders holdings for Urovant Sciences Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. See Footnote (1) |
2021-03-30 12:12:59 | 22,963,479 0 |
22,963,479 | Form 13D |
| 2 | QVT Associates GP LLC QVT Fund V LP 10% Owner |
2018-10-03 17:50:59 | 0 22,703,669 |
22,703,669 | Form 4 |
| 3 | Katkin Keith PEO;CEO/Urovant Sciences, Inc. |
2020-02-21 18:42:57 | 976,146 0 |
976,146 | Form 4 |
| 4 | McFadden Michael E. CCO/Urovant Sciences, Inc. |
2019-01-08 17:24:23 | 100,000 0 |
100,000 | Form 4 |
| 5 | Ebersole Nori SVP;CHRO/Urovant Sciences, Inc |
2019-01-08 17:20:01 | 65,000 0 |
65,000 | Form 4 |
| 6 | Torti Frank Director |
2019-07-11 13:17:01 | 25,000 0 |
25,000 | Form 4 |
| 7 | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. |
2021-03-31 12:30:45 | 0 0 |
0 | Form 4 |
| 8 | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. |
2021-03-31 12:30:43 | 0 0 |
0 | Form 4 |
| 9 | Legault Pierre Director |
2021-03-31 12:30:39 | 0 0 |
0 | Form 4 |
| 10 | Kurstjens Sef Director |
2021-03-31 12:30:35 | 0 0 |
0 | Form 4 |
| 11 | Johnston Walt See Remarks |
2021-03-31 12:30:31 | 0 0 |
0 | Form 4 |
| 12 | Hindman James M. Director |
2021-03-31 12:30:36 | 0 0 |
0 | Form 4 |
| 13 | BANSAL AJAY See Remarks |
2021-03-31 12:30:38 | 0 0 |
0 | Form 4 |
| 14 | Smith Bryan E. GC/Urovant Sciences, Inc. |
2021-03-31 12:30:26 | 0 0 |
0 | Form 4 |
| 15 | OCAMPO CHRISTINE PAO; CAO/Urovant Sciences,Inc. |
2021-03-31 12:30:24 | 0 0 |
0 | Form 4 |
| 16 | POTTER MYRTLE S Director |
2021-03-31 12:30:18 | 0 0 |
0 | Form 4 |
| 17 | Nishinaka Shigeyuki Director |
2020-01-06 16:06:22 | 0 0 |
0 | Form 3 |
| 18 | Roivant Sciences Ltd. 10% Owner |
2019-12-31 16:45:49 | 0 0 |
0 | Form 4 |
| 19 | Lo Andrew Former 10% Owner |
2019-07-16 17:41:32 | 0 0 |
0 | Form 13D |
| 20 | Machado Patrick Former 10% Owner |
2019-07-16 17:31:47 | 0 0 |
0 | Form 13D |
| 21 | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan See remarks |
2019-07-12 16:51:48 | 0 0 |
0 | Form 4 |
| 22 | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner |
2019-07-12 20:32:10 | 0 0 |
0 | Form 4 |
| 23 | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner |
2019-07-12 20:31:04 | 0 0 |
0 | Form 4 |
| 24 | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP Former 10% Owner |
2019-07-12 19:51:50 | 0 0 |
0 | Form 4 |
| 25 | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
2019-07-12 16:25:32 | 0 0 |
0 | Form 4 |